NCT02965976 2023-02-16
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
Roswell Park Cancer Institute
Norwegian University of Science and Technology
Mayo Clinic
St. Olavs Hospital
Centre hospitalier de l'Université de Montréal (CHUM)
Georgetown University